This study sought to assess whether intracoronary adenosine or nitroprusside following thrombus aspiration (TA) is superior to TA alone for the prevention of microvascular obstruction (MVO) in ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI).
Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction) / Niccoli, Giampaolo; Rigattieri, Stefano; De Vita, Maria; Valgimigli, M; Corvo, P; Fabbiocchi, F; Romagnoli, Enrico; De Caterina, Alberto; La Torre, G; Lo Schiavo, P; Tarantino, F; Ferrari, R; Tomai, F; Olivares, P; Cosentino, Nicola; D'Amario, Domenico; Leone, Antonio Maria; Porto, Italo; Burzotta, Francesco; Trani, Carlo; Crea, Filippo. - In: JACC: CARDIOVASCULAR INTERVENTIONS. - ISSN 1936-8798. - 6:6(2013), pp. 580-589. [10.1016/j.jcin.2013.02.009]
Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction)
Niccoli, Giampaolo;
2013-01-01
Abstract
This study sought to assess whether intracoronary adenosine or nitroprusside following thrombus aspiration (TA) is superior to TA alone for the prevention of microvascular obstruction (MVO) in ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
